Usage of heparan sulfate, integrins, and FAK in HPV16 infection

Virology

Volumn 403, Issue 1, 2010, Pages 1-16

  Abban, Cynthia Y ^a   Meneses, Patricio I ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Activation; Endocytosis; Endosomes; FAK; HPV16; Infection; Phosphorylation; Src

Indexed keywords

2 [5 CHLORO 2 (2 METHOXY 4 MORPHOLINOANILINO) 4 PYRIMIDINYLAMINO] N METHYLBENZAMIDE; FOCAL ADHESION KINASE; HEPARAN SULFATE; INTEGRIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS ATTACHMENT; VIRUS INHIBITION; VIRUS PARTICLE;

CELL LINE; FOCAL ADHESION KINASE 1; HEPARITIN SULFATE; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; INTEGRIN ALPHA6; KERATINOCYTES; MORPHOLINES; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 77953291134     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.04.007     Document Type: Article

References (50)

1. Abban C.Y., Bradbury N.A., Meneses P.I. HPV16 and BPV1 infection can be blocked by the dynamin inhibitor dynasore. Am. J. Ther. 2008, 15(4):304-311.
2. Berditchevski F., Odintsova E. Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J. Cell Biol. 1999, 146(2):477-492.
3. Bosch F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., Schiffman M.H., Moreno V., Kurman R., Shah K.V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J. Natl. Cancer Inst. 1995, 87(11):796-802.
4. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., Shah K.V. The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol. 2002, 55(4):244-265.
5. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106(3):761-771.
6. Boukamp P., Popp S., Altmeyer S., Hulsen A., Fasching C., Cremer T., Fusenig N.E. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer 1997, 19(4):201-214.
7. Bousarghin L., Touze A., Sizaret P.Y., Coursaget P. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 2003, 77(6):3846-3850.
8. Breitkreutz D., Schoop V.M., Mirancea N., Baur M., Stark H.J., Fusenig N.E. Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur. J. Cell Biol. 1998, 75(3):273-286.
9. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 2004, 78(2):751-757.
10. Cheshenko N., Liu W., Satlin L.M., Herold B.C. Focal adhesion kinase plays a pivotal role in herpes simplex virus entry. J. Biol. Chem. 2005, 280(35):31116-31125.
11. Dabydeen S.A., Meneses P.I. The role of NH4Cl and cysteine proteases in human papillomavirus type 16 infection. Virol. J. 2009, 6(1):109.
12. Davis C.B., Dikic I., Unutmaz D., Hill C.M., Arthos J., Siani M.A., Thompson D.A., Schlessinger J., Littman D.R. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 1997, 186(10):1793-1798.
13. Day P.M., Lowy D.R., Schiller J.T. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003, 307(1):1-11.
14. Day P.M., Thompson C.D., Buck C.B., Pang Y.Y., Lowy D.R., Schiller J.T. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J. Virol. 2007, 81(16):8784-8792.
15. Evander M., Frazer I.H., Payne E., Qi Y.M., Hengst K., McMillan N.A. Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J. Virol. 1997, 71(3):2449-2456.
16. Fothergill T., McMillan N.A. Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. Virology 2006, 352(2):319-328.
17. Gache Y., Romero-Graillet C., Spadafora A., Lepinard C., Descamps P., Bardon C.B., Ortonne J.P., Meneguzzi G. A novel homozygous mutation affecting integrin alpha6 in a case of junctional epidermolysis bullosa with pyloric atresia detected in utero by ultrasound examination. J. Invest. Dermatol. 1998, 111(5):914-916.
18. Girouglou T., Florin L., Schafer F., Streeck R.E., Sapp M. Human papillomavirus infection requires cell surface heparan sulfate. J. Virol. 2001, 75(3):1565-1570.
19. Hildebrand J.D., Schaller M.D., Parsons J.T. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp 125FAK, to cellular focal adhesions. J. Cell Biol. 1993, 123(4):993-1005.
20. Hindmarsh P.L., Laimins L.A. Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol. J. 2007, 4:19.
21. Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., Nomura S., Fujimoto J., Okada M., Yamamoto T. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995, 377(6549):539-544.
22. Johnson K.M., Kines R.C., Roberts J.N., Lowy D.R., Schiller J.T., Day P.M. Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J. Virol. 2009, 83(5):2067-2074.
23. Joyce J.G., Tung J.S., Przysiecki C.T., Cook J.C., Lehman E.D., Sands J.A., Jansen K.U., Keller P.M. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J. Biol. Chem. 1999, 274(9):5810-5822.
24. Krishnan H.H., Sharma-Walia N., Streblow D.N., Naranatt P.P., Chandran B. Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells. J. Virol. 2006, 80(3):1167-1180.
25. Laniosz V., Holthusen K.A., Meneses P.I. Bovine papillomavirus type 1: from clathrin to caveolin. J. Virol. 2008, 82(13):6288-6298.
26. Laniosz V., Dabydeen S.A., Havens M.A., Meneses P.I. Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J. Virol. 2009, 83(16):8221-8232.
27. Liu Ta-Jen, LaFortune Tiffany, Honda Toshiyuki, Ohmori Osamu, Hatakeyama Shinji, Meyer Thomas, Jackson Dowdy, de Groot John, Yung W.K.Alfred Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Mol. Cancer Ther. 2007, 6(4):1357-1367.
28. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124(4):729-740.
29. Mattila P.K., Lappalainen P. Filopodia: molecular architecture and cellular functions. Nat. Rev. Mol. Cell Biol. 2008, 9(6):446-454.
30. McMillan N.A., Payne E., Frazer I.H., Evander M. Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 1999, 261(2):271-279.
31. Naranatt P.P., Akula S.M., Zien C.A., Krishnan H.H., Chandran B. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J. Virol. 2003, 77(2):1524-1539.
32. Natarajan K., Ghalayini A.J., Sterling R.S., Holbrook R.M., Kennedy R.C., Chodosh J. Activation of focal adhesion kinase in adenovirus-infected human corneal fibroblasts. Invest. Ophthalmol. Vis. Sci. 2002, 43(8):2685-2690.
33. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 2003, 116(Pt 8):1409-1416.
34. Payne E., Bowles M.R., Don A., Hancock J.F., McMillan N.A. Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation. J. Virol. 2001, 75(9):4150-4157.
35. Querbes W., Benmerah A., Tosoni D., Di Fiore P.P., Atwood W.J. A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. J. Virol. 2004, 71(8):6247-6252.
36. Roberts J.N., Buck C.B., Thompson C.D., Kines R., Bernardo M., Choyke P.L., Lowy D.R., Schiller J.T. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat. Med. 2007, 13(7):857-861.
37. Rommel O., Dillner J., Fligge C., Bergsdorf C., Wang X., Selinka H.C., Sapp M. Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: basis for a virus-like particle ELISA. J. Med. Virol. 2005, 75(1):114-121.
38. Schaller M.D., Hildebrand J.D., Shannon J.D., Fox J.W., Vines R.R., Parsons J.T. Autophosphorylation of the focal adhesion kinase, pp 125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 1994, 14(3):1680-1688.
39. Schelhaas M., Ewers H., Rajamaki M.L., Day P.M., Schiller J.T., Helenius A. Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog. 2008, 4(9):e1000148.
40. Selinka H.C., Giroglou T., Sapp M. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 2002, 299(2):279-287.
41. Selinka H.C., Giroglou T., Nowak T., Christensen N.D., Sapp M. Further evidence that papillomavirus capsids exist in two distinct conformations. J. Virol. 2003, 77(24):12961-12967.
42. Shafti-Keramat S., Handisurya A. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomavirus. J. Virol. 2003, 77(24):13125-13135.
43. Sharma-Walia N., Naranatt P.P., Krishnan H.H., Zeng L., Chandran B. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements. J. Virol. 2004, 78(8):4207-4223.
44. Sieg D.J., Ilic D., Jones K.C., Damsky C.H., Hunter T., Schlaepfer D.D. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration. EMBO J. 1998, 17(20):5933-5947.
45. Sieg D.J., Hauck C.R., Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J. Cell Sci. 1999, 112:2677-2691.
46. Slack-Davis J.K., Martin K.H., Tilghman R.W., Iwanicki M., Ung E.J., Autry C., Luzzio M.J., Cooper B., Kath J.C., Roberts W.G., Parsons J.T. Cellular characterization of a novel focal adhesion kinase inhibitor. J. Biol. Chem. 2007, 282(20):14845-14852.
47. Smith J.L., Campos S.K., Ozbun M.A. Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J. Virol. 2007, 81(18):9922-9931.
48. Smith J.L., Lidke D.S., Ozbun M.A. Virus activated filopodia promote human papillomavirus type 31 uptake from the extracellular matrix. Virology 2008, 381(1):16-21.
49. Spoden G., Freitag K., Husmann M., Boller K., Sapp M., Lambert C., Florin L. Clathrin- and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspanin-enriched microdomains (TEMs). PLoS ONE 2008, 3(10):e3313.
50. Zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991, 184:9-13.